A potent, cost-effective RNase inhibitor

Area of Science:

• Molecular Biology
• Biochemistry
• Enzymology

Background:

• Ribonucleases (RNases) degrade RNA, posing a challenge in molecular biology experiments.
• Existing RNase inhibitors, such as human placental RNase inhibitors (HPRI), have limitations in stability and cost-effectiveness.

Purpose of the Study:

• To evaluate the performance characteristics of a novel protein-based RNase inhibitor, PRIME Inhibitor.
• To assess the applicability of PRIME Inhibitor in various molecular biology techniques.

Main Methods:

• Characterization of PRIME Inhibitor's specific activity, temperature stability, and pH range.
• Comparative analysis against commercial human placental RNase inhibitors (HPRI).
• Testing PRIME Inhibitor's efficacy in key molecular biology applications.

Main Results:

• PRIME Inhibitor exhibits high specific activity and enhanced temperature stability.
• It demonstrates a broad reaction pH range and superior cost-effectiveness compared to HPRI.
• PRIME Inhibitor proved effective in in vitro transcription, translation, cDNA synthesis, RNA preparation, and RT-PCR.

Conclusions:

• PRIME Inhibitor is a potent and versatile RNase inhibitor.
• Its unique protein nature and enhanced properties make it a superior alternative to HPRI.
• PRIME Inhibitor offers a cost-effective solution for diverse RNA-based molecular biology workflows.